Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106995807B reveals high-activity transaminase for Sitagliptin. Enables cost reduction in pharmaceutical intermediates manufacturing with superior enantioselectivity.
Novel engineered ketoreductase enables high optical purity synthesis of chiral intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113234113A details organic catalysis for 1,2-cis-glycosidic bonds. Enhances supply chain reliability and cost efficiency for vaccine antigen manufacturing.
Patent CN108530331B details a rare earth amide catalyzed method for thiocarbamate synthesis offering high purity and mild conditions for pharmaceutical and agrochemical intermediate manufacturing.
Novel ionic liquid catalyst method for high-purity 2-nitro-4-methylsulfonyltoluene. Enhances selectivity for mesotrione production with reduced waste and scalable manufacturing capabilities.
Patent CN100381451C details a novel ruthenocene ligand synthesis. We offer scalable production for high-purity asymmetric catalysis applications with cost-effective supply chain solutions.
Patent CN112028842A reveals a novel synthetic route for quizalofop-p-ethyl offering enhanced purity and reduced environmental waste for global supply chains.
Discover a streamlined preparation method for Aztreonam intermediates using ion exchange resin catalysis. Achieve higher yields and reduced production cycles for reliable pharmaceutical supply chains.
Patent CN108503573A reveals a novel ZnCl2-catalyzed route for Brivaracetam. Eliminate chiral columns for significant cost reduction and supply chain reliability in API manufacturing.
Patent CN114644602A reveals a safer, high-yield route for dihydroisoxazole intermediates. Discover cost-effective manufacturing solutions for topramezone precursors.
Novel enzyme mutant enables high-purity drug intermediate synthesis with improved conversion rates and industrial scalability for global supply chains.
Patent CN107653238B reveals immobilized biocatalysis for statin intermediates. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable solutions.
Patent CN112501223B details a one-step enzymatic route for statin side chains, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN120574796A enables high-purity (S)-nornicotine production. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN1592788A reveals non-GMO bioconversion for alpha-ketobutyrate. Enhances supply chain safety and reduces chemical synthesis costs for flavor manufacturers.
Patent CN101671366A details an eco-friendly synthesis of phenylphosphonic dichloride using recyclable Lewis acid ionic liquids, offering significant cost reduction and simplified purification for fine chemical intermediates.
Patent CN115341009B details enzyme solution reuse for steroid synthesis. Reduces cost and improves yield for pharmaceutical intermediates manufacturing supply chains.
Novel BF3-catalyzed glucoside preparation offers high purity and scalability. Optimize supply chain for pharmaceutical intermediates with green chemistry.
Patent CN102942592B reveals ionic liquid catalysis for BPBPD. Achieve high purity, reduced waste, and scalable supply for antioxidant intermediates.
Novel catalytic method for diphenylphosphine chloride ensures high yield and purity. Ideal for reliable fine chemical intermediates supplier partnerships seeking cost reduction.